

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.38197752 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.05220932 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.05220932 |
| 4 | protein retention in ER lumen (GO:0006621) | 5.00156885 |
| 5 | regulation of chronic inflammatory response (GO:0002676) | 4.66172462 |
| 6 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.62734367 |
| 7 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.61726124 |
| 8 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 4.59967597 |
| 9 | regulation of mononuclear cell migration (GO:0071675) | 4.43165599 |
| 10 | virion attachment to host cell (GO:0019062) | 4.29808402 |
| 11 | adhesion of symbiont to host cell (GO:0044650) | 4.29808402 |
| 12 | nephron tubule morphogenesis (GO:0072078) | 4.26898315 |
| 13 | nephron epithelium morphogenesis (GO:0072088) | 4.26898315 |
| 14 | positive regulation of heat generation (GO:0031652) | 4.21892255 |
| 15 | signal peptide processing (GO:0006465) | 4.13035056 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.11977608 |
| 17 | regulation of fever generation (GO:0031620) | 4.08305563 |
| 18 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.88978970 |
| 19 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.86976207 |
| 20 | monocyte chemotaxis (GO:0002548) | 3.79635211 |
| 21 | adhesion of symbiont to host (GO:0044406) | 3.78467378 |
| 22 | renal tubule morphogenesis (GO:0061333) | 3.76757982 |
| 23 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.76645424 |
| 24 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.76622386 |
| 25 | negative regulation of amino acid transport (GO:0051956) | 3.75760983 |
| 26 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.74623584 |
| 27 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.73353729 |
| 28 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.72109677 |
| 29 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.67408935 |
| 30 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.58488377 |
| 31 | regulation of vitamin metabolic process (GO:0030656) | 3.55261100 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55092099 |
| 33 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.48236936 |
| 34 | renal absorption (GO:0070293) | 3.43215193 |
| 35 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.41333657 |
| 36 | myeloid dendritic cell differentiation (GO:0043011) | 3.39545661 |
| 37 | oligosaccharide catabolic process (GO:0009313) | 3.37751551 |
| 38 | glycosphingolipid catabolic process (GO:0046479) | 3.36888418 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 3.34603433 |
| 40 | regulation of podosome assembly (GO:0071801) | 3.34459861 |
| 41 | creatine metabolic process (GO:0006600) | 3.31767109 |
| 42 | response to peptidoglycan (GO:0032494) | 3.30639026 |
| 43 | regulation of chemokine biosynthetic process (GO:0045073) | 3.29470318 |
| 44 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.25518338 |
| 45 | metanephric tubule development (GO:0072170) | 3.22944758 |
| 46 | metanephric nephron tubule development (GO:0072234) | 3.22944758 |
| 47 | regulation of immunoglobulin secretion (GO:0051023) | 3.20490036 |
| 48 | regulation of heat generation (GO:0031650) | 3.20072793 |
| 49 | eosinophil chemotaxis (GO:0048245) | 3.19600224 |
| 50 | facial nerve structural organization (GO:0021612) | 3.18449893 |
| 51 | T-helper 1 type immune response (GO:0042088) | 3.17515071 |
| 52 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.13820477 |
| 53 | response to corticosterone (GO:0051412) | 3.13430578 |
| 54 | regulation of cholesterol storage (GO:0010885) | 3.12517480 |
| 55 | response to protozoan (GO:0001562) | 3.10784511 |
| 56 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.09257631 |
| 57 | COPII vesicle coating (GO:0048208) | 3.07726625 |
| 58 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.06448118 |
| 59 | metanephric nephron epithelium development (GO:0072243) | 3.06009334 |
| 60 | * activation of MAPKKK activity (GO:0000185) | 3.02442846 |
| 61 | mitochondrial calcium ion transport (GO:0006851) | 3.01765774 |
| 62 | macrophage activation involved in immune response (GO:0002281) | 2.99709613 |
| 63 | glycolipid catabolic process (GO:0019377) | 2.98786188 |
| 64 | nephron tubule development (GO:0072080) | 2.98677764 |
| 65 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.98283272 |
| 66 | collecting duct development (GO:0072044) | 2.96816971 |
| 67 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.96372661 |
| 68 | complement activation, alternative pathway (GO:0006957) | 2.94230333 |
| 69 | response to copper ion (GO:0046688) | 2.93417277 |
| 70 | reactive oxygen species biosynthetic process (GO:1903409) | 2.92252762 |
| 71 | collagen fibril organization (GO:0030199) | 2.90316394 |
| 72 | germinal center formation (GO:0002467) | 2.89190020 |
| 73 | wound healing, spreading of cells (GO:0044319) | 2.88724455 |
| 74 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.88355827 |
| 75 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.87260148 |
| 76 | exocrine pancreas development (GO:0031017) | 2.87160259 |
| 77 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.86366840 |
| 78 | omega-hydroxylase P450 pathway (GO:0097267) | 2.86206176 |
| 79 | response to progesterone (GO:0032570) | 2.85895204 |
| 80 | tryptophan catabolic process (GO:0006569) | 2.85621700 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 2.85621700 |
| 82 | indolalkylamine catabolic process (GO:0046218) | 2.85621700 |
| 83 | cellular response to lipopolysaccharide (GO:0071222) | 2.85564317 |
| 84 | cellular response to type I interferon (GO:0071357) | 2.85007330 |
| 85 | type I interferon signaling pathway (GO:0060337) | 2.85007330 |
| 86 | response to mineralocorticoid (GO:0051385) | 2.84493887 |
| 87 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.84203719 |
| 88 | metanephric epithelium development (GO:0072207) | 2.83985064 |
| 89 | basement membrane organization (GO:0071711) | 2.83864190 |
| 90 | lung epithelium development (GO:0060428) | 2.83026971 |
| 91 | regulation of interferon-alpha production (GO:0032647) | 2.82195133 |
| 92 | amine catabolic process (GO:0009310) | 2.81909410 |
| 93 | cellular biogenic amine catabolic process (GO:0042402) | 2.81909410 |
| 94 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.81360135 |
| 95 | defense response to protozoan (GO:0042832) | 2.81251632 |
| 96 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.81066455 |
| 97 | cellular response to nicotine (GO:0071316) | 2.81020601 |
| 98 | response to type I interferon (GO:0034340) | 2.79246291 |
| 99 | cell adhesion mediated by integrin (GO:0033627) | 2.78545297 |
| 100 | eosinophil migration (GO:0072677) | 2.78430374 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.76481659 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.76481659 |
| 103 | renal tubule development (GO:0061326) | 2.76121542 |
| 104 | endocrine pancreas development (GO:0031018) | 2.75753242 |
| 105 | chondrocyte proliferation (GO:0035988) | 2.75501497 |
| 106 | wound healing, spreading of epidermal cells (GO:0035313) | 2.74849424 |
| 107 | membrane lipid catabolic process (GO:0046466) | 2.74263919 |
| 108 | cellular response to molecule of bacterial origin (GO:0071219) | 2.73777544 |
| 109 | sequestering of metal ion (GO:0051238) | 2.73025790 |
| 110 | Notch signaling involved in heart development (GO:0061314) | 2.72839624 |
| 111 | regulation of circadian sleep/wake cycle (GO:0042749) | 2.71756711 |
| 112 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.71756711 |
| 113 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.71597260 |
| 114 | circadian sleep/wake cycle process (GO:0022410) | 2.71406087 |
| 115 | epoxygenase P450 pathway (GO:0019373) | 2.71065112 |
| 116 | regulation of macrophage chemotaxis (GO:0010758) | 2.70997870 |
| 117 | positive regulation of lipid storage (GO:0010884) | 2.70928833 |
| 118 | gland morphogenesis (GO:0022612) | 2.70314293 |
| 119 | sphingolipid catabolic process (GO:0030149) | 2.69821416 |
| 120 | atrioventricular valve morphogenesis (GO:0003181) | 2.69241201 |
| 121 | negative regulation of lipid storage (GO:0010888) | 2.68930192 |
| 122 | low-density lipoprotein particle clearance (GO:0034383) | 2.68573300 |
| 123 | ceramide catabolic process (GO:0046514) | 2.67683139 |
| 124 | response to muramyl dipeptide (GO:0032495) | 2.65905891 |
| 125 | ER overload response (GO:0006983) | 2.64944156 |
| 126 | positive regulation of nuclease activity (GO:0032075) | 2.64439391 |
| 127 | metanephric mesenchyme development (GO:0072075) | 2.63920146 |
| 128 | endothelial cell proliferation (GO:0001935) | 2.63446889 |
| 129 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.62943967 |
| 130 | detection of molecule of bacterial origin (GO:0032490) | 2.61853800 |
| 131 | glycerophospholipid catabolic process (GO:0046475) | 2.60303665 |
| 132 | regulation of norepinephrine secretion (GO:0014061) | 2.60266835 |
| 133 | aromatic amino acid family catabolic process (GO:0009074) | 2.60262981 |
| 134 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.59712083 |
| 135 | negative regulation of sterol transport (GO:0032372) | 2.59174627 |
| 136 | negative regulation of cholesterol transport (GO:0032375) | 2.59174627 |
| 137 | myeloid dendritic cell activation (GO:0001773) | 2.58171609 |
| 138 | response to gravity (GO:0009629) | 2.58060493 |
| 139 | positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737) | 2.57814200 |
| 140 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.57752593 |
| 141 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.57495650 |
| 142 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.56938721 |
| 143 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.55586622 |
| 144 | response to fluid shear stress (GO:0034405) | 2.55504116 |
| 145 | response to inactivity (GO:0014854) | 2.55138150 |
| 146 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54762597 |
| 147 | cellular response to unfolded protein (GO:0034620) | 2.54480122 |
| 148 | dendritic cell differentiation (GO:0097028) | 2.53791388 |
| 149 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.53377721 |
| 150 | plasma lipoprotein particle clearance (GO:0034381) | 2.53269130 |
| 151 | regulation of glutamate secretion (GO:0014048) | 2.53119772 |
| 152 | negative regulation of growth of symbiont in host (GO:0044130) | 2.52357333 |
| 153 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.52357333 |
| 154 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.52357333 |
| 155 | regulation of growth of symbiont in host (GO:0044126) | 2.52357333 |
| 156 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.52227914 |
| 157 | negative regulation of fatty acid transport (GO:2000192) | 2.52086443 |
| 158 | protein maturation by protein folding (GO:0022417) | 2.50640648 |
| 159 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.48800165 |
| 160 | skin morphogenesis (GO:0043589) | 2.47608328 |
| 161 | nitric oxide mediated signal transduction (GO:0007263) | 2.46707157 |
| 162 | glandular epithelial cell differentiation (GO:0002067) | 2.46544539 |
| 163 | negative regulation of complement activation (GO:0045916) | 2.46491072 |
| 164 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.46346710 |
| 165 | nephron epithelium development (GO:0072009) | 2.45666823 |
| 166 | regulation of male gonad development (GO:2000018) | 2.45210271 |
| 167 | cellular response to ATP (GO:0071318) | 2.44052636 |
| 168 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.43942082 |
| 169 | negative regulation of bone resorption (GO:0045779) | 2.43423833 |
| 170 | cornea development in camera-type eye (GO:0061303) | 2.43392382 |
| 171 | cellular response to topologically incorrect protein (GO:0035967) | 2.42167250 |
| 172 | positive regulation of cartilage development (GO:0061036) | 2.41711155 |
| 173 | response to follicle-stimulating hormone (GO:0032354) | 2.40401882 |
| 174 | keratan sulfate catabolic process (GO:0042340) | 2.39341940 |
| 175 | xenobiotic catabolic process (GO:0042178) | 2.38530480 |
| 176 | kidney mesenchyme development (GO:0072074) | 2.37640775 |
| 177 | mesonephric tubule development (GO:0072164) | 2.36831673 |
| 178 | lymphangiogenesis (GO:0001946) | 2.36756976 |
| 179 | mature B cell differentiation involved in immune response (GO:0002313) | 2.36297920 |
| 180 | regulation of nuclease activity (GO:0032069) | 2.35885356 |
| 181 | positive regulation of steroid hormone secretion (GO:2000833) | 2.35313951 |
| 182 | ER-nucleus signaling pathway (GO:0006984) | 2.34118524 |
| 183 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.33835700 |
| 184 | regulation of plasminogen activation (GO:0010755) | 2.33741873 |
| 185 | protein heterotrimerization (GO:0070208) | 2.32923071 |
| 186 | positive regulation of extracellular matrix organization (GO:1903055) | 2.32181615 |
| 187 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.31945762 |
| 188 | peptide hormone processing (GO:0016486) | 2.31176970 |
| 189 | endothelial cell morphogenesis (GO:0001886) | 2.30987435 |
| 190 | muscle cell migration (GO:0014812) | 2.30983013 |
| 191 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.30948648 |
| 192 | extracellular fibril organization (GO:0043206) | 2.30619961 |
| 193 | mesonephric epithelium development (GO:0072163) | 2.30141849 |
| 194 | positive regulation of collagen metabolic process (GO:0010714) | 2.30139279 |
| 195 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29721766 |
| 196 | cellular response to vitamin D (GO:0071305) | 2.29254346 |
| 197 | cellular response to vitamin (GO:0071295) | 2.28677043 |
| 198 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.26666682 |
| 199 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.26348975 |
| 200 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.26022024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.45729966 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.74222666 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.40180965 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.85799195 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.05308603 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.92836966 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.88371435 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.75222399 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.72341768 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.68756841 |
| 11 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.60291639 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34928402 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.31582140 |
| 14 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.30541019 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15541934 |
| 16 | CJUN_26792858_Chip-Seq_BT549_Human | 2.09703563 |
| 17 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.07427608 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04128770 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.03392702 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.02585757 |
| 21 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.99368996 |
| 22 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.99132638 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.96508534 |
| 24 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.96220444 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.95128498 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93318486 |
| 27 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.86469776 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.80766863 |
| 29 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.77075072 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75870102 |
| 31 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.75376318 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74717564 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.72964102 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72436825 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.71294292 |
| 36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.71166213 |
| 37 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69399697 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63941727 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62858048 |
| 40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62601534 |
| 41 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.59657076 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54310010 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52561164 |
| 44 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51804570 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50480939 |
| 46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50070487 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49061797 |
| 48 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46871128 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44345781 |
| 50 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43491480 |
| 51 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.43367752 |
| 52 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43116792 |
| 53 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41786318 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40889350 |
| 55 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.40744825 |
| 56 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.40744825 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40281754 |
| 58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38143831 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.37420481 |
| 60 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.35347076 |
| 61 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.33189436 |
| 62 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.33047867 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32850374 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29731838 |
| 65 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28919096 |
| 66 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.28448018 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26431624 |
| 68 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25682437 |
| 69 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24474923 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23660456 |
| 71 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23366900 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22175561 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.22062701 |
| 74 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20673438 |
| 75 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20457224 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19316604 |
| 77 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.19019639 |
| 78 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.19019639 |
| 79 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.19019639 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18947401 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18582555 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.18099504 |
| 83 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17367318 |
| 84 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.17205955 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17146558 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17146558 |
| 87 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17111926 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16541487 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16244980 |
| 90 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16193021 |
| 91 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.16162407 |
| 92 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.15191775 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14834937 |
| 94 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14648747 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14472210 |
| 96 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13782094 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13576531 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.13443182 |
| 99 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12628778 |
| 100 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12628778 |
| 101 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.12283476 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11619061 |
| 103 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11203055 |
| 104 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11037266 |
| 105 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10095168 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08459704 |
| 107 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08285077 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08194642 |
| 109 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.08184497 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08038354 |
| 111 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06644423 |
| 112 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06616883 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06583181 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05943448 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05608150 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04507563 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03123710 |
| 118 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02318835 |
| 119 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01517959 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01486119 |
| 121 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01204917 |
| 122 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01116692 |
| 123 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00852608 |
| 124 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00584698 |
| 125 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99922462 |
| 126 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99470185 |
| 127 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99206443 |
| 128 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.98901133 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98708407 |
| 130 | P68_20966046_ChIP-Seq_HELA_Human | 0.98369336 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97541814 |
| 132 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97374301 |
| 133 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97344101 |
| 134 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97235092 |
| 135 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.96547070 |
| 136 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96538218 |
| 137 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94789389 |
| 138 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94416054 |
| 139 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93957699 |
| 140 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93547663 |
| 141 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93315883 |
| 142 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92682604 |
| 143 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92660793 |
| 144 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92360807 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91966488 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91836077 |
| 147 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91521817 |
| 148 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90660193 |
| 149 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90452339 |
| 150 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90452339 |
| 151 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90397192 |
| 152 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90327163 |
| 153 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89906759 |
| 154 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89521280 |
| 155 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89336234 |
| 156 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.89323699 |
| 157 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87903081 |
| 158 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87782406 |
| 159 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87622157 |
| 160 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87412896 |
| 161 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87217722 |
| 162 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86991465 |
| 163 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85904731 |
| 164 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83011910 |
| 165 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.82568640 |
| 166 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82349716 |
| 167 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81565834 |
| 168 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81241341 |
| 169 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80815875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.51226471 |
| 2 | MP0003279_aneurysm | 4.49716561 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.74964681 |
| 4 | MP0009840_abnormal_foam_cell | 3.35344094 |
| 5 | MP0005503_abnormal_tendon_morphology | 3.27058716 |
| 6 | MP0006082_CNS_inflammation | 3.13890101 |
| 7 | * MP0002148_abnormal_hypersensitivity_rea | 2.92666583 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.76384806 |
| 9 | MP0009785_altered_susceptibility_to | 2.67094023 |
| 10 | MP0004272_abnormal_basement_membrane | 2.63305911 |
| 11 | MP0003724_increased_susceptibility_to | 2.57220281 |
| 12 | MP0002653_abnormal_ependyma_morphology | 2.55262135 |
| 13 | MP0002928_abnormal_bile_duct | 2.51552588 |
| 14 | MP0005275_abnormal_skin_tensile | 2.49420341 |
| 15 | MP0003436_decreased_susceptibility_to | 2.47983571 |
| 16 | MP0001542_abnormal_bone_strength | 2.44679425 |
| 17 | MP0010368_abnormal_lymphatic_system | 2.43701723 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.41365724 |
| 19 | MP0003075_altered_response_to | 2.35058559 |
| 20 | MP0005220_abnormal_exocrine_pancreas | 2.34740373 |
| 21 | MP0000013_abnormal_adipose_tissue | 2.26096773 |
| 22 | MP0001958_emphysema | 2.22743266 |
| 23 | MP0009384_cardiac_valve_regurgitation | 2.12013192 |
| 24 | MP0000604_amyloidosis | 2.09861341 |
| 25 | MP0005257_abnormal_intraocular_pressure | 2.08750859 |
| 26 | MP0005451_abnormal_body_composition | 2.04771516 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 2.04189360 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.97939364 |
| 29 | MP0003045_fibrosis | 1.96258644 |
| 30 | MP0001790_abnormal_immune_system | 1.93272287 |
| 31 | MP0005387_immune_system_phenotype | 1.93272287 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.92355769 |
| 33 | MP0010030_abnormal_orbit_morphology | 1.92133543 |
| 34 | MP0005508_abnormal_skeleton_morphology | 1.90380985 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.88415356 |
| 36 | MP0005671_abnormal_response_to | 1.86063214 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.85643469 |
| 38 | MP0000749_muscle_degeneration | 1.84421703 |
| 39 | MP0005025_abnormal_response_to | 1.80267678 |
| 40 | MP0005084_abnormal_gallbladder_morpholo | 1.78464770 |
| 41 | MP0008004_abnormal_stomach_pH | 1.73862398 |
| 42 | MP0003690_abnormal_glial_cell | 1.70598979 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.69119172 |
| 44 | MP0002419_abnormal_innate_immunity | 1.69079669 |
| 45 | MP0003252_abnormal_bile_duct | 1.67375090 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.63264747 |
| 47 | MP0006054_spinal_hemorrhage | 1.60964297 |
| 48 | MP0003646_muscle_fatigue | 1.58168057 |
| 49 | MP0000678_abnormal_parathyroid_gland | 1.56780636 |
| 50 | MP0005670_abnormal_white_adipose | 1.56066701 |
| 51 | MP0003453_abnormal_keratinocyte_physiol | 1.55500837 |
| 52 | MP0003566_abnormal_cell_adhesion | 1.53179457 |
| 53 | MP0001853_heart_inflammation | 1.49729400 |
| 54 | MP0001944_abnormal_pancreas_morphology | 1.48464236 |
| 55 | MP0005390_skeleton_phenotype | 1.47623147 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.45115329 |
| 57 | MP0003329_amyloid_beta_deposits | 1.44522625 |
| 58 | MP0000003_abnormal_adipose_tissue | 1.44021338 |
| 59 | MP0002295_abnormal_pulmonary_circulatio | 1.42173483 |
| 60 | MP0008469_abnormal_protein_level | 1.41346581 |
| 61 | MP0002168_other_aberrant_phenotype | 1.40481622 |
| 62 | MP0005023_abnormal_wound_healing | 1.39868968 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.38168454 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.38058112 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.37452961 |
| 66 | MP0000767_abnormal_smooth_muscle | 1.35712255 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.35053595 |
| 68 | MP0002933_joint_inflammation | 1.34598066 |
| 69 | MP0000343_altered_response_to | 1.32840303 |
| 70 | MP0005365_abnormal_bile_salt | 1.32805912 |
| 71 | * MP0002723_abnormal_immune_serum | 1.31842954 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.31641266 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.29960047 |
| 74 | MP0010155_abnormal_intestine_physiology | 1.29152536 |
| 75 | MP0001270_distended_abdomen | 1.28647437 |
| 76 | MP0004947_skin_inflammation | 1.28363080 |
| 77 | MP0001835_abnormal_antigen_presentation | 1.27395435 |
| 78 | MP0003941_abnormal_skin_development | 1.26578164 |
| 79 | MP0003385_abnormal_body_wall | 1.25624673 |
| 80 | MP0005166_decreased_susceptibility_to | 1.24890228 |
| 81 | MP0000163_abnormal_cartilage_morphology | 1.23819739 |
| 82 | MP0002452_abnormal_antigen_presenting | 1.23638882 |
| 83 | MP0003879_abnormal_hair_cell | 1.20998980 |
| 84 | MP0005164_abnormal_response_to | 1.20521745 |
| 85 | MP0009780_abnormal_chondrocyte_physiolo | 1.20326918 |
| 86 | MP0001800_abnormal_humoral_immune | 1.19912160 |
| 87 | MP0001501_abnormal_sleep_pattern | 1.17542861 |
| 88 | MP0003283_abnormal_digestive_organ | 1.17022202 |
| 89 | MP0005083_abnormal_biliary_tract | 1.15365402 |
| 90 | MP0002249_abnormal_larynx_morphology | 1.15324487 |
| 91 | MP0004043_abnormal_pH_regulation | 1.14349567 |
| 92 | MP0008961_abnormal_basal_metabolism | 1.13629938 |
| 93 | MP0003195_calcinosis | 1.13363408 |
| 94 | MP0003300_gastrointestinal_ulcer | 1.12842557 |
| 95 | MP0002254_reproductive_system_inflammat | 1.09722054 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.07978562 |
| 97 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07798123 |
| 98 | MP0000049_abnormal_middle_ear | 1.07467772 |
| 99 | MP0002060_abnormal_skin_morphology | 1.07180138 |
| 100 | MP0009643_abnormal_urine_homeostasis | 1.06607358 |
| 101 | MP0002693_abnormal_pancreas_physiology | 1.06520793 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 1.06379920 |
| 103 | MP0000750_abnormal_muscle_regeneration | 1.05768106 |
| 104 | MP0003942_abnormal_urinary_system | 1.05099165 |
| 105 | MP0005310_abnormal_salivary_gland | 1.04834207 |
| 106 | MP0003795_abnormal_bone_structure | 1.04443148 |
| 107 | MP0004858_abnormal_nervous_system | 1.01198306 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 1.00825003 |
| 109 | MP0005666_abnormal_adipose_tissue | 1.00686565 |
| 110 | MP0004883_abnormal_blood_vessel | 1.00258559 |
| 111 | MP0005165_increased_susceptibility_to | 0.99325072 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.99185086 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.99185086 |
| 114 | MP0003943_abnormal_hepatobiliary_system | 0.98956237 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.98251836 |
| 116 | MP0009764_decreased_sensitivity_to | 0.98217210 |
| 117 | MP0000920_abnormal_myelination | 0.97963909 |
| 118 | MP0003828_pulmonary_edema | 0.97305971 |
| 119 | MP0005595_abnormal_vascular_smooth | 0.96954406 |
| 120 | MP0003634_abnormal_glial_cell | 0.96895969 |
| 121 | MP0005535_abnormal_body_temperature | 0.96716006 |
| 122 | MP0001243_abnormal_dermal_layer | 0.96014265 |
| 123 | MP0000534_abnormal_ureter_morphology | 0.94304858 |
| 124 | MP0002139_abnormal_hepatobiliary_system | 0.94145996 |
| 125 | MP0009278_abnormal_bone_marrow | 0.93332252 |
| 126 | MP0009333_abnormal_splenocyte_physiolog | 0.92606811 |
| 127 | MP0003303_peritoneal_inflammation | 0.90416265 |
| 128 | MP0002163_abnormal_gland_morphology | 0.90247245 |
| 129 | MP0001756_abnormal_urination | 0.90190884 |
| 130 | MP0005647_abnormal_sex_gland | 0.87694715 |
| 131 | MP0001502_abnormal_circadian_rhythm | 0.86572629 |
| 132 | MP0005623_abnormal_meninges_morphology | 0.86470479 |
| 133 | MP0001663_abnormal_digestive_system | 0.86125026 |
| 134 | MP0002932_abnormal_joint_morphology | 0.85882557 |
| 135 | * MP0001819_abnormal_immune_cell | 0.85299883 |
| 136 | * MP0002420_abnormal_adaptive_immunity | 0.85174312 |
| 137 | MP0002405_respiratory_system_inflammati | 0.83889801 |
| 138 | MP0002113_abnormal_skeleton_development | 0.82078910 |
| 139 | MP0000685_abnormal_immune_system | 0.81483955 |
| 140 | MP0009765_abnormal_xenobiotic_induced | 0.80687092 |
| 141 | MP0009763_increased_sensitivity_to | 0.80574258 |
| 142 | MP0000249_abnormal_blood_vessel | 0.80440426 |
| 143 | MP0002108_abnormal_muscle_morphology | 0.80353070 |
| 144 | MP0004510_myositis | 0.79170958 |
| 145 | MP0000538_abnormal_urinary_bladder | 0.79144017 |
| 146 | MP0002115_abnormal_skeleton_extremities | 0.78062212 |
| 147 | MP0000858_altered_metastatic_potential | 0.76375395 |
| 148 | MP0003633_abnormal_nervous_system | 0.74888540 |
| 149 | MP0008874_decreased_physiological_sensi | 0.73735662 |
| 150 | MP0003091_abnormal_cell_migration | 0.72984778 |
| 151 | MP0002128_abnormal_blood_circulation | 0.72391233 |
| 152 | MP0003137_abnormal_impulse_conducting | 0.72089890 |
| 153 | MP0005266_abnormal_metabolism | 0.71451726 |
| 154 | MP0000230_abnormal_systemic_arterial | 0.71225086 |
| 155 | MP0001764_abnormal_homeostasis | 0.70874005 |
| 156 | MP0002277_abnormal_respiratory_mucosa | 0.70632907 |
| 157 | MP0005332_abnormal_amino_acid | 0.69342946 |
| 158 | MP0002909_abnormal_adrenal_gland | 0.68493464 |
| 159 | MP0003448_altered_tumor_morphology | 0.67824737 |
| 160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67673988 |
| 161 | MP0000609_abnormal_liver_physiology | 0.67500074 |
| 162 | MP0002118_abnormal_lipid_homeostasis | 0.67386342 |
| 163 | MP0001765_abnormal_ion_homeostasis | 0.67366574 |
| 164 | MP0000733_abnormal_muscle_development | 0.67198016 |
| 165 | MP0002269_muscular_atrophy | 0.66845620 |
| 166 | MP0000613_abnormal_salivary_gland | 0.66014019 |
| 167 | MP0003183_abnormal_peptide_metabolism | 0.65880289 |
| 168 | MP0005319_abnormal_enzyme/_coenzyme | 0.65775763 |
| 169 | MP0002234_abnormal_pharynx_morphology | 0.64890014 |
| 170 | MP0002078_abnormal_glucose_homeostasis | 0.64425153 |
| 171 | MP0005375_adipose_tissue_phenotype | 0.63204478 |
| 172 | MP0005334_abnormal_fat_pad | 0.62956929 |
| 173 | MP0001727_abnormal_embryo_implantation | 0.62067886 |
| 174 | MP0003186_abnormal_redox_activity | 0.60661155 |
| 175 | MP0003123_paternal_imprinting | 0.53957997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.09536240 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.09536240 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.09536240 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 6.52038477 |
| 5 | Premature rupture of membranes (HP:0001788) | 5.54312016 |
| 6 | Cerebral aneurysm (HP:0004944) | 5.42233755 |
| 7 | Complement deficiency (HP:0004431) | 4.90062719 |
| 8 | Disinhibition (HP:0000734) | 4.75723003 |
| 9 | Glomerulonephritis (HP:0000099) | 4.60041831 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.59689247 |
| 11 | Neurofibrillary tangles (HP:0002185) | 4.47022505 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 4.37367965 |
| 13 | Protrusio acetabuli (HP:0003179) | 4.36233767 |
| 14 | Loss of speech (HP:0002371) | 4.23110171 |
| 15 | Nuclear cataract (HP:0100018) | 4.16308817 |
| 16 | Axonal loss (HP:0003447) | 4.05152531 |
| 17 | Mutism (HP:0002300) | 3.99296456 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.81787518 |
| 19 | Optic neuritis (HP:0100653) | 3.81787518 |
| 20 | Orchitis (HP:0100796) | 3.66248904 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.58210657 |
| 22 | Abnormality of complement system (HP:0005339) | 3.56199684 |
| 23 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.50813482 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.46722490 |
| 25 | Vertebral compression fractures (HP:0002953) | 3.45871479 |
| 26 | Abnormality of dentin (HP:0010299) | 3.37831313 |
| 27 | Aortic aneurysm (HP:0004942) | 3.32372159 |
| 28 | Atrophic scars (HP:0001075) | 3.29453662 |
| 29 | Cerebral inclusion bodies (HP:0100314) | 3.21380377 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.14525379 |
| 31 | Increased connective tissue (HP:0009025) | 3.13955268 |
| 32 | Fragile skin (HP:0001030) | 3.08967045 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 3.08448545 |
| 34 | Stomatitis (HP:0010280) | 3.07694107 |
| 35 | Abnormal pancreas size (HP:0012094) | 3.05571187 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 3.04225239 |
| 37 | Short nail (HP:0001799) | 3.02161545 |
| 38 | Hypoglycemic seizures (HP:0002173) | 3.01186368 |
| 39 | Myositis (HP:0100614) | 3.00969403 |
| 40 | Aortic dissection (HP:0002647) | 2.97938711 |
| 41 | Increased serum ferritin (HP:0003281) | 2.96070219 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.92227060 |
| 43 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.90692699 |
| 44 | Spinal rigidity (HP:0003306) | 2.87569935 |
| 45 | Hyperactive renin-angiotensin system (HP:0000841) | 2.86823720 |
| 46 | Purpura (HP:0000979) | 2.85217399 |
| 47 | Soft skin (HP:0000977) | 2.84374530 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.76281447 |
| 49 | Neoplasm of the adrenal cortex (HP:0100641) | 2.75195995 |
| 50 | Inappropriate behavior (HP:0000719) | 2.72620411 |
| 51 | Prolonged neonatal jaundice (HP:0006579) | 2.71926886 |
| 52 | Diminished motivation (HP:0000745) | 2.68517962 |
| 53 | Progressive neurologic deterioration (HP:0002344) | 2.62071909 |
| 54 | Apathy (HP:0000741) | 2.61544859 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.59897780 |
| 56 | Aneurysm (HP:0002617) | 2.59304529 |
| 57 | Stomach cancer (HP:0012126) | 2.57206051 |
| 58 | Symptomatic seizures (HP:0011145) | 2.53655987 |
| 59 | Mesangial abnormality (HP:0001966) | 2.50101991 |
| 60 | Blue sclerae (HP:0000592) | 2.49111029 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 2.48938539 |
| 62 | Peritonitis (HP:0002586) | 2.47881079 |
| 63 | Biconcave vertebral bodies (HP:0004586) | 2.46590295 |
| 64 | Retinal atrophy (HP:0001105) | 2.46301515 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 2.43577051 |
| 66 | Anomalous pulmonary venous return (HP:0010772) | 2.43457299 |
| 67 | Bladder diverticulum (HP:0000015) | 2.43053068 |
| 68 | Xanthomatosis (HP:0000991) | 2.42005390 |
| 69 | Unilateral renal agenesis (HP:0000122) | 2.41967392 |
| 70 | Dilatation of the ascending aorta (HP:0005111) | 2.40750777 |
| 71 | Cystic liver disease (HP:0006706) | 2.39819553 |
| 72 | Bowel diverticulosis (HP:0005222) | 2.39587613 |
| 73 | Amyloidosis (HP:0011034) | 2.39271719 |
| 74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.39096116 |
| 75 | Renal cortical cysts (HP:0000803) | 2.35211705 |
| 76 | Abnormality of iron homeostasis (HP:0011031) | 2.33862637 |
| 77 | Right ventricular cardiomyopathy (HP:0011663) | 2.33839190 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 2.33563960 |
| 79 | Dementia (HP:0000726) | 2.33053725 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.32326246 |
| 81 | Wormian bones (HP:0002645) | 2.32219408 |
| 82 | Gangrene (HP:0100758) | 2.31617542 |
| 83 | Nephritis (HP:0000123) | 2.31191399 |
| 84 | Nausea (HP:0002018) | 2.30844630 |
| 85 | Recurrent abscess formation (HP:0002722) | 2.28548333 |
| 86 | Broad metatarsal (HP:0001783) | 2.27954082 |
| 87 | Agnosia (HP:0010524) | 2.26966154 |
| 88 | Follicular hyperkeratosis (HP:0007502) | 2.26014690 |
| 89 | Shallow orbits (HP:0000586) | 2.25749180 |
| 90 | Personality changes (HP:0000751) | 2.22340490 |
| 91 | Eczematoid dermatitis (HP:0000976) | 2.22219733 |
| 92 | Neoplasm of the adrenal gland (HP:0100631) | 2.22035153 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.21339932 |
| 94 | Abnormality of proline metabolism (HP:0010907) | 2.17822473 |
| 95 | Hydroxyprolinuria (HP:0003080) | 2.17822473 |
| 96 | Bulbar palsy (HP:0001283) | 2.15127018 |
| 97 | Abnormality of the pulmonary veins (HP:0011718) | 2.14510672 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 2.14002247 |
| 99 | Intrahepatic cholestasis (HP:0001406) | 2.13938622 |
| 100 | Generalized aminoaciduria (HP:0002909) | 2.13870914 |
| 101 | Cervical subluxation (HP:0003308) | 2.13442621 |
| 102 | Difficulty climbing stairs (HP:0003551) | 2.12390601 |
| 103 | Keratoconjunctivitis (HP:0001096) | 2.12290995 |
| 104 | Spondylolisthesis (HP:0003302) | 2.11102228 |
| 105 | Late onset (HP:0003584) | 2.09445825 |
| 106 | Mitral stenosis (HP:0001718) | 2.09068522 |
| 107 | Exocrine pancreatic insufficiency (HP:0001738) | 2.06968425 |
| 108 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06030285 |
| 109 | Parakeratosis (HP:0001036) | 2.04759485 |
| 110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02452354 |
| 111 | Metaphyseal irregularity (HP:0003025) | 2.02225054 |
| 112 | Muscle fiber splitting (HP:0003555) | 2.01573329 |
| 113 | Gout (HP:0001997) | 2.01469122 |
| 114 | Peripheral demyelination (HP:0011096) | 2.00742662 |
| 115 | Hyperglycemia (HP:0003074) | 2.00139251 |
| 116 | Deep venous thrombosis (HP:0002625) | 1.99227249 |
| 117 | Insulin resistance (HP:0000855) | 1.99089214 |
| 118 | Increased IgM level (HP:0003496) | 1.98316880 |
| 119 | Nonimmune hydrops fetalis (HP:0001790) | 1.97954519 |
| 120 | Acne (HP:0001061) | 1.96819689 |
| 121 | Abnormal delivery (HP:0001787) | 1.94213511 |
| 122 | Chondrocalcinosis (HP:0000934) | 1.93524208 |
| 123 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.92084252 |
| 124 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91734516 |
| 125 | Malnutrition (HP:0004395) | 1.91213034 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91193243 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.91193243 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91037738 |
| 129 | Abnormality of lateral ventricle (HP:0030047) | 1.91027210 |
| 130 | Polyphagia (HP:0002591) | 1.90782279 |
| 131 | Decreased subcutaneous fat (HP:0001002) | 1.90591507 |
| 132 | Basal ganglia calcification (HP:0002135) | 1.89982988 |
| 133 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.88322637 |
| 134 | Supranuclear gaze palsy (HP:0000605) | 1.88320946 |
| 135 | Memory impairment (HP:0002354) | 1.88027046 |
| 136 | Beaking of vertebral bodies (HP:0004568) | 1.87498172 |
| 137 | Pathologic fracture (HP:0002756) | 1.86403694 |
| 138 | Neonatal hypoglycemia (HP:0001998) | 1.86201953 |
| 139 | Growth hormone excess (HP:0000845) | 1.85963477 |
| 140 | Polyneuropathy (HP:0001271) | 1.85950720 |
| 141 | Vascular tortuosity (HP:0004948) | 1.85875086 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.85267853 |
| 143 | Neonatal short-limb short stature (HP:0008921) | 1.83945126 |
| 144 | Abnormality of Sharpey fibers (HP:0100685) | 1.83838259 |
| 145 | Menorrhagia (HP:0000132) | 1.83467365 |
| 146 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.82239951 |
| 147 | Ulnar deviation of the wrist (HP:0003049) | 1.82204103 |
| 148 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.81510463 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.81280356 |
| 150 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81134111 |
| 151 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81134111 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81134111 |
| 153 | Ketoacidosis (HP:0001993) | 1.80027000 |
| 154 | Joint stiffness (HP:0001387) | 1.78385723 |
| 155 | Hyperparathyroidism (HP:0000843) | 1.76601579 |
| 156 | Pulmonary artery stenosis (HP:0004415) | 1.76402095 |
| 157 | Hyperlipoproteinemia (HP:0010980) | 1.76288730 |
| 158 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76119390 |
| 159 | Joint laxity (HP:0001388) | 1.75982750 |
| 160 | Ectopia lentis (HP:0001083) | 1.75955367 |
| 161 | Myoglobinuria (HP:0002913) | 1.75877411 |
| 162 | Round ear (HP:0100830) | 1.74751116 |
| 163 | Persistence of primary teeth (HP:0006335) | 1.72319236 |
| 164 | Muscle fiber inclusion bodies (HP:0100299) | 1.71678952 |
| 165 | Alopecia of scalp (HP:0002293) | 1.71071867 |
| 166 | Thin ribs (HP:0000883) | 1.70155272 |
| 167 | Dysostosis multiplex (HP:0000943) | 1.69929458 |
| 168 | Urinary incontinence (HP:0000020) | 1.69726391 |
| 169 | Hyperextensible skin (HP:0000974) | 1.69673871 |
| 170 | Hepatoblastoma (HP:0002884) | 1.68764934 |
| 171 | Agitation (HP:0000713) | 1.68592549 |
| 172 | J-shaped sella turcica (HP:0002680) | 1.67949360 |
| 173 | Myocardial infarction (HP:0001658) | 1.67118866 |
| 174 | Hypoalphalipoproteinemia (HP:0003233) | 1.66334180 |
| 175 | Cardiomegaly (HP:0001640) | 1.66191194 |
| 176 | Abnormality of the intrinsic pathway (HP:0010989) | 1.65473969 |
| 177 | Knee flexion contracture (HP:0006380) | 1.65440813 |
| 178 | Hemoptysis (HP:0002105) | 1.64073562 |
| 179 | Tarsal synostosis (HP:0008368) | 1.63508267 |
| 180 | Hepatosplenomegaly (HP:0001433) | 1.63036575 |
| 181 | Hypokalemia (HP:0002900) | 1.62307468 |
| 182 | Pulmonary embolism (HP:0002204) | 1.62046302 |
| 183 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.62015541 |
| 184 | Osteopenia (HP:0000938) | 1.61621148 |
| 185 | Congenital glaucoma (HP:0001087) | 1.61249034 |
| 186 | Nemaline bodies (HP:0003798) | 1.60638152 |
| 187 | Hyperuricemia (HP:0002149) | 1.60462948 |
| 188 | Increased purine levels (HP:0004368) | 1.60462948 |
| 189 | Joint swelling (HP:0001386) | 1.58839142 |
| 190 | Obstructive lung disease (HP:0006536) | 1.57131480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 5.39934385 |
| 2 | MAPK15 | 4.90066550 |
| 3 | NME2 | 4.64698607 |
| 4 | ERN1 | 3.97982228 |
| 5 | EPHA3 | 3.54485852 |
| 6 | TAOK1 | 2.88459300 |
| 7 | RIPK1 | 2.43926355 |
| 8 | MAP2K2 | 2.29457603 |
| 9 | INSRR | 2.26401332 |
| 10 | TIE1 | 1.99362725 |
| 11 | PIK3CG | 1.90236202 |
| 12 | TESK1 | 1.87614419 |
| 13 | MAP3K3 | 1.86425258 |
| 14 | PIM2 | 1.85461949 |
| 15 | PRKCH | 1.79048613 |
| 16 | BCKDK | 1.71605945 |
| 17 | ABL2 | 1.68601570 |
| 18 | PASK | 1.62616198 |
| 19 | TGFBR2 | 1.61582476 |
| 20 | BLK | 1.60020434 |
| 21 | TYRO3 | 1.59077713 |
| 22 | EPHB1 | 1.56158562 |
| 23 | FER | 1.50755199 |
| 24 | LIMK1 | 1.48568085 |
| 25 | TRIB3 | 1.47958536 |
| 26 | TTN | 1.39499326 |
| 27 | IRAK4 | 1.38860301 |
| 28 | MYLK | 1.37647131 |
| 29 | TXK | 1.33397752 |
| 30 | EPHB2 | 1.31602702 |
| 31 | TAOK2 | 1.31588383 |
| 32 | FGR | 1.28762103 |
| 33 | PKN1 | 1.28745969 |
| 34 | PTK2 | 1.28671437 |
| 35 | FGFR4 | 1.28142740 |
| 36 | ICK | 1.26779019 |
| 37 | OBSCN | 1.25396593 |
| 38 | IRAK3 | 1.23069505 |
| 39 | MAP2K1 | 1.22922764 |
| 40 | MAP2K6 | 1.21132355 |
| 41 | TBK1 | 1.20044928 |
| 42 | MAP3K14 | 1.19422765 |
| 43 | KDR | 1.17702172 |
| 44 | MAP3K5 | 1.16550020 |
| 45 | PTK2B | 1.13318419 |
| 46 | MAP2K3 | 1.10265828 |
| 47 | PAK2 | 1.08669098 |
| 48 | MAPKAPK3 | 1.08449705 |
| 49 | ERBB3 | 1.07454336 |
| 50 | DYRK3 | 1.07298375 |
| 51 | PRKG2 | 1.06571492 |
| 52 | EPHA2 | 1.01315329 |
| 53 | HIPK2 | 1.00371949 |
| 54 | DAPK2 | 0.98697065 |
| 55 | PRKD3 | 0.98626575 |
| 56 | CHUK | 0.98537285 |
| 57 | PAK3 | 0.96770806 |
| 58 | TYK2 | 0.96562209 |
| 59 | PTK6 | 0.94230244 |
| 60 | RPS6KA4 | 0.93218033 |
| 61 | MAP4K1 | 0.92856403 |
| 62 | IRAK1 | 0.92123754 |
| 63 | PRKD2 | 0.89350996 |
| 64 | ARAF | 0.84424862 |
| 65 | TGFBR1 | 0.83950225 |
| 66 | CAMKK2 | 0.82499243 |
| 67 | IKBKB | 0.82238219 |
| 68 | SIK3 | 0.81825644 |
| 69 | STK38L | 0.77386842 |
| 70 | PIK3CA | 0.77353930 |
| 71 | PHKG2 | 0.77151523 |
| 72 | PHKG1 | 0.77151523 |
| 73 | CSK | 0.76110637 |
| 74 | IRAK2 | 0.75898928 |
| 75 | DAPK3 | 0.75059593 |
| 76 | MAPK4 | 0.74821412 |
| 77 | CAMK1D | 0.73220964 |
| 78 | JAK3 | 0.73125710 |
| 79 | PINK1 | 0.72390546 |
| 80 | WNK4 | 0.71797875 |
| 81 | SIK2 | 0.71129954 |
| 82 | RPS6KL1 | 0.70699249 |
| 83 | RPS6KC1 | 0.70699249 |
| 84 | SGK2 | 0.70618026 |
| 85 | SGK223 | 0.70614780 |
| 86 | SGK494 | 0.70614780 |
| 87 | MOS | 0.68617734 |
| 88 | PRPF4B | 0.68095240 |
| 89 | ACVR1B | 0.67764888 |
| 90 | LYN | 0.66162844 |
| 91 | MAPK7 | 0.65744707 |
| 92 | PDGFRA | 0.64958365 |
| 93 | MARK2 | 0.63149421 |
| 94 | CDK3 | 0.62941559 |
| 95 | GSK3A | 0.62481637 |
| 96 | RPS6KA6 | 0.61882078 |
| 97 | MAP3K11 | 0.60932309 |
| 98 | NEK6 | 0.58621509 |
| 99 | DYRK1B | 0.58323591 |
| 100 | ADRBK2 | 0.57723208 |
| 101 | LMTK2 | 0.57712950 |
| 102 | MAPKAPK2 | 0.56740481 |
| 103 | WNK3 | 0.56398165 |
| 104 | RPS6KA2 | 0.56109621 |
| 105 | NLK | 0.53061257 |
| 106 | CDK9 | 0.52769261 |
| 107 | JAK1 | 0.52266887 |
| 108 | DDR2 | 0.51846592 |
| 109 | JAK2 | 0.50977743 |
| 110 | MARK1 | 0.50639321 |
| 111 | MAP3K13 | 0.50025909 |
| 112 | EPHA4 | 0.49687145 |
| 113 | FRK | 0.49323417 |
| 114 | TNK2 | 0.48947706 |
| 115 | LATS1 | 0.48890617 |
| 116 | MATK | 0.48291563 |
| 117 | PRKAA2 | 0.48089822 |
| 118 | BMPR2 | 0.47336135 |
| 119 | SIK1 | 0.47318438 |
| 120 | LATS2 | 0.47060065 |
| 121 | MUSK | 0.47036075 |
| 122 | RIPK4 | 0.46785123 |
| 123 | NME1 | 0.46155532 |
| 124 | NEK9 | 0.45619234 |
| 125 | PRKD1 | 0.45503768 |
| 126 | RPS6KA5 | 0.44403466 |
| 127 | LCK | 0.44291188 |
| 128 | MARK3 | 0.44167826 |
| 129 | CAMK2D | 0.44044680 |
| 130 | MAP4K2 | 0.43912788 |
| 131 | MAP3K1 | 0.43529906 |
| 132 | IKBKE | 0.43250705 |
| 133 | CAMK2G | 0.41575188 |
| 134 | SGK3 | 0.41400451 |
| 135 | CDC42BPA | 0.41080780 |
| 136 | TRPM7 | 0.40371491 |
| 137 | FGFR3 | 0.40326784 |
| 138 | ROCK1 | 0.39240866 |
| 139 | PIM1 | 0.37927878 |
| 140 | MAP3K10 | 0.36747191 |
| 141 | ERBB4 | 0.36597104 |
| 142 | PRKCE | 0.36476647 |
| 143 | GRK7 | 0.36356224 |
| 144 | RPS6KA1 | 0.35115897 |
| 145 | CAMK4 | 0.33856740 |
| 146 | ZAP70 | 0.33649061 |
| 147 | DMPK | 0.33506619 |
| 148 | PRKCZ | 0.32889707 |
| 149 | SYK | 0.32185765 |
| 150 | CSF1R | 0.31730745 |
| 151 | PRKACG | 0.29846212 |
| 152 | FES | 0.27860535 |
| 153 | MAP2K7 | 0.27793107 |
| 154 | NTRK3 | 0.27387871 |
| 155 | BTK | 0.26395225 |
| 156 | NTRK2 | 0.26218189 |
| 157 | BMX | 0.23444834 |
| 158 | PDPK1 | 0.22930562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.87097664 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.91714455 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83728840 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76062692 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.44429999 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.22229980 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.15961327 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.13982912 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07466198 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.02688697 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.90912099 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.89854603 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.87396652 |
| 14 | Salmonella infection_Homo sapiens_hsa05132 | 1.82544711 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79233998 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.78598329 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74893285 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.69455867 |
| 19 | Bladder cancer_Homo sapiens_hsa05219 | 1.65911361 |
| 20 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.63697070 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.57948396 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.57125034 |
| 23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.54382807 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.53946029 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.52766622 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44421373 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43232424 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39490350 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.38721895 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.38671650 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38645270 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37326613 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36934608 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.36793475 |
| 35 | Focal adhesion_Homo sapiens_hsa04510 | 1.34493048 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31556433 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30495718 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27210863 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26897128 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22711109 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22246157 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.21446157 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.20221552 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16744183 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11058927 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 1.10958015 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07184137 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06541218 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06508512 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05989590 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05981919 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 1.03767201 |
| 53 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03226994 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.02188432 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.01540022 |
| 56 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01155367 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.99616041 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96977410 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96204517 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.96055637 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95977050 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.95851792 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94643227 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93648545 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93480929 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92916477 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91682212 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90857455 |
| 69 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.87218128 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85411365 |
| 71 | Mineral absorption_Homo sapiens_hsa04978 | 0.85136300 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.84957445 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83518433 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82120477 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80969509 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.79655589 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78832431 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.77039168 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76448656 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76291967 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75311840 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75231614 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.74708862 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74469396 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.73134523 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70387014 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69476724 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67472491 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65878271 |
| 90 | * Apoptosis_Homo sapiens_hsa04210 | 0.65345009 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64796685 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63795256 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.63629990 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63168505 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62005568 |
| 96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61305312 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60838089 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60027112 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59553884 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.58054710 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55999961 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55101394 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54963239 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52748509 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52607844 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52041230 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51816926 |
| 108 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50996217 |
| 109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49570252 |
| 110 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48870999 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.47606182 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46687578 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44815948 |
| 114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44684839 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.44632999 |
| 116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44494417 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44101220 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.43873513 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43662125 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42677875 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41130546 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40433198 |
| 123 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40224850 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.39228289 |
| 125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39169496 |
| 126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39138921 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.38567444 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38561461 |
| 129 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38351346 |
| 130 | Prostate cancer_Homo sapiens_hsa05215 | 0.38082337 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37775801 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37720546 |
| 133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37670539 |
| 134 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37200510 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37102795 |
| 136 | Melanoma_Homo sapiens_hsa05218 | 0.36031611 |
| 137 | * p53 signaling pathway_Homo sapiens_hsa04115 | 0.35357238 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35174349 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34775444 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34692079 |
| 141 | Hepatitis B_Homo sapiens_hsa05161 | 0.34677285 |
| 142 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34106669 |
| 143 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33856411 |
| 144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33424771 |
| 145 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31822554 |
| 146 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.31510575 |
| 147 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31360537 |
| 148 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28750429 |
| 149 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26738198 |

